Inventor
THORMANN MICHAEL
DE17 patents
⚠️ This page may combine multiple inventors who share the name “THORMANN MICHAEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NOVARTIS AG
4 patentsUS7504436B2Mar 17, 2009
Bioisosteres of actinonin
NOVARTIS AG8 citations82
US7932255B2Apr 26, 2011
2-aminocarbonyl substituted piperazine or diaza-cyclic compounds as apoptosis protein inhibitors (lap) modulators
NOVARTIS AG1 citations45
US7705037B2Apr 27, 2010
1-substituted pyrrolidin-2-ones and use thereof as peptide deformylase inhibitors
NOVARTIS AG0 citations40
US7662833B2Feb 16, 2010
Imidazo [1,2-A] pyridine derivatives useful as peptide deformylase (PDF) inhibitors
NOVARTIS AG0 citations40
THORMANN MICHAEL
4 patentsUS9802937B2Oct 31, 2017
Substituted pyrazolo{4,3-D}pyrimidines as kinase inhibitors
THORMANN MICHAEL9 citations79
US9499535B2Nov 22, 2016
Kinase inhibitors
THORMANN MICHAEL2 citations57
US8420684B2Apr 16, 2013
Inhibitors of glutaminyl cyclase
THORMANN MICHAEL0 citations37
US8278345B2Oct 2, 2012
Inhibitors of glutaminyl cyclase
THORMANN MICHAEL0 citations37
ORIGENIS GMBH
4 patentsUS10000482B2Jun 19, 2018
Kinase inhibitors
ORIGENIS GMBH2 citations68
US9637491B2May 2, 2017
Pyrazolo[4,3-D]pyrimidines as kinase inhibitors
ORIGENIS GMBH2 citations68
US10752624B2Aug 25, 2020
Kinase inhibitors
ORIGENIS GMBH0 citations47
US12384788B2Aug 12, 2025
1,4-dihydrobenzo[d]pyrazolo[3,4-f][1,3]diazepine derivatives and related compounds as LRRK2, NUAK1 and/or TYK2 kinase modulators for the treatment of e.g. autoimmune disease
ORIGENIS GMBH0 citations44